| English Alias: |
eFT508;eFT-508;Tomivosertib;Tomivosertib free base;U2H19X4WBV;6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione;6'-[(6-aminopyrimidin-4-yl)amino]-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione;6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione;Tomivosertib [INN];Tomivosertib [USAN];UNII-U2H19X4WBV;eFT508; Tomivosertib;EFT 508;BDBM50263263;Spiro(cyclohexane-1,3'(2'H)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-amino-4-pyrimidinyl)amino)-8'-methyl-;NSC791783;compound 23 [PMID: 29526098];AC-35882;AKOS030627405;eFT-508 (eFT508);CS-5841;NCGC00492296-03;BE168437;D11452;NSC791784;NSC804952;6'-[(6-aminopyrimidin-4-yl)amino]-8'-methyl-2',5'-dihydro-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione;DTXSID601022534;BCP18993;1849590-01-7;TOMIVOSERTIB [WHO-DD];D71143;NSC-791783;Z2740419312;DB15219;S8275;HY-100022;CHEMBL4073443;6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione;eFT-508 HCl;eFT508(Tomivosertib)?;GTPL10167;Tomivosertib (USAN/INN);NSC-791784;CCG-267922;BS-16162;6'-((6-AMINOPYRIMIDIN-4-YL)AMINO)-8'-METHYL-2'HSPIRO(CYCLOHEXANE-1,3'-IMIDAZO(1,5-A)PYRIDINE)-1',5'-DIONE;eFT508 HCl;SCHEMBL17362622;NSC-804952;DA-63118;GLXC-10728;Tomivosertib [USAN:INN];EX-A2494;6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'(2'H)-dione;N45 |